Cannasouth and Eqalis' $48.8m 'merger' plans

Cannasouth and Eqalis' $48.8m 'merger' plans
Mark Lucas says it eliminates cost duplication at both firms. (Image: NZME)
Staff reporters
Cannasouth dropped 5% to 28.5 cents after the medicinal cannabis firm said it would pay $48.8 million for Equalis Pharmaceuticals in an all-scrip deal. It would also seek to raise another $9m to fund the enlarged group's working capital.The NZ stock exchange listed firm, based in Waikato, said it would issue 147.9m new Cannasouth shares at an issue price of 33c, doubling the number of shares on issue, and describing the transaction as a 'merger of equals'.Bay of Plenty-based Eqalis, founded in 2019, brings on board its capacity...

More Health

Solar-powered hospitals possible
Health

Solar-powered hospitals possible

Sunlight may be more than disinfectant.

Ian Llewellyn 16 Oct 2025
Southern Cross pays record 3.8 million claims
Law & Regulation

Southern Cross pays record 3.8 million claims

Rising demand and more frequent claims push up costs, directly impacting premiums.

John Anthony 30 Sep 2025
Fisher & Paykel Healthcare shares dip on new tariff fears
Markets

Fisher & Paykel Healthcare shares dip on new tariff fears

US Department of Commerce launched a “Section 232” on medical products.

Gregor Thompson 25 Sep 2025
NZer creates world's first waste-free drink
Retail

NZer creates world's first waste-free drink

They are tiny, concentrated balls of flavours and vitamins which dissolve in liquid.